Showing 99 of 99on this page. Filters & sort apply to loaded results; URL updates for sharing.99 of 99 on this page
Company Introduction Biogen Investor Funding Elevator Pitch Deck PPT ...
Sample Group Assignement - D. INTRODUCTION i. Company Background BioGen ...
Biogen - Medicines Discovery Catapult
Biogen Looks To Bulk Up Rare Disease Portfolio With $7.3 Billion ...
Code of Business Conduct | Biogen
Biogen CEO bets on Alzheimer's drug, pipeline to return to growth | Reuters
The Biogen Logo History, Colors, Font, And Meaning
Why Biogen may have the most lucrative product in pharmaceutical history
Biogen receives FDA approval for breakthrough ALS treatment: 'Pivotal ...
Biogen Buys Biotech Firm HI-Bio to Boost Its Immunology Portfolio
2024 Corporate Responsibility Report | Biogen
Biogen in up to $1.8 bln deal as rare diseases take center stage ...
Biogen Uses its Own Superspreader Event to Aid COVID-19 Research | The ...
In dramatic turn, Biogen seeks FDA approval for experimental Alzheimer ...
Biogen - Generis
We’re transforming our research approach at Biogen to uncover… | Biogen
Biogen Research Triangle Park at Kimberly Bosch blog
Sobre a Biogen
Biogen Brochure - CDR | PDF
Biogen on LinkedIn: #biogen #innovation
Flat Is The New Up As Biogen Anticipates Stabilizing Product Revenue In ...
Biogen Moves forward with Potential Alzheimer's Drug, Seeks US Approval
How a Biogen drug set the stage for a new biotech targeting ALS ...
Biogen licenses a possible immune drug from OrbiMed-backed biotech ...
Year in Review | Biogen
Biogen to buy immunology startup HI-Bio, set up Bay Area team - San ...
FDA Approves New Alzheimer's Drug But Creators Biogen And Eisai Stock ...
Student Programs | Biogen
Leadership shift sets Biogen ANZ on course for next-phase growth ...
Biogen Opts To Retain Biosimilars Business
170 Group Project - Biogen, Inc. Table of Contents Introduction ...
Building the New Biogen | Biogen
Our U.S. Legacy | Biogen
Careers | Biogen
Biogen präsentiert neue Litifilimab-Phase-2-Daten zu CLE auf der AAD 2
Biogen pays $70M upfront to Vanqua Bio for immunology drug
Environment | Biogen
Biogen - Communication et marketing santé - Massaï Médical
Biogen Bolsters Immune Disease Pipeline with $1.8 Billion Acquisition ...
Biogen Logo
Biogen axes phase 2 study of lung-scarring med due to 'safety concerns ...
Investors Research Corp Takes Position in Biogen Inc. $BIIB
Biogen grows immunology and rare disease portfolio with Apellis buyout ...
Biogen plans to present its advances in Alzheimer’s and Parkinson’s ...
Biogen acquires Apellis Pharmaceuticals for $5.6 billion - Boston ...
Biogen raises 2024 financial guidance as Leqembi sales pick up - Boston ...
Biogen Beefs Up Immuno Pipeline with Potential $1.8B HI-Bio Acquisition ...
Biogen Automates Purchasing with Compleat
60+ Biogen Pictures
Biogen Revives Alzheimer's Drug After Huge Breakthrough; Stock Soars
Biogen Announces New Global Headquarters at Kendall Common, Cambridge
Biogen opens a branch in Estonia: Europe has lots to learn from Estonia ...
Biogen wins approval for pioneering treatment for rare disease
Biogen doubles down on biosimilars pact with Samsung Bioepis, bagging ...
Earnings Preview: What To Expect From Biogen On Thursday
Why Biogen Is Spinning Off its Hemophilia Drug Business | Fortune
Life at Biogen
Biogen investing $2 billion in North Carolina ahead of 2028 product ...
Biogen on LinkedIn: Learn more about the Care+ mobile app
15 Biogen logo Stock Pictures, Editorial Images and Stock Photos ...
Biogen Profile (EXPANDED) | PDF
Eisai, Biogen say Alzheimer's drug succeeds in slowing cognitive ...
Biogen signs agreement to acquire Reata for $7.3bn | Pharmaceutical ...
Biogen Projects | Photos, videos, logos, illustrations and branding on ...
Biogen Reviews | Glassdoor
Biogen ends 17-Year Aduhelm alzheimer's drug study - Mugglehead ...
Biogen Reaches Research Deal With Dayra in Immunology Push
Biogen to cut 1,000 jobs as focus turns to Alzheimer's drug Leqembi ...
Biogen Internships 2026 For Practical Career Insights - Internships Orbit
Biogen touts new evidence from the gene therapy company it wagered $800M on
Biogen Jobs and Company Culture
Biogen Conference Teaches Us an Important Lesson – The Panel Online
Early Access Programs | Biogen
Biogen to unveil new data supporting broad use of infant disease drug ...
Biogen bets $10M on implant to improve delivery of Spinraza
Biogen to acquire privately held Human Immunology Biosciences for $1.15 ...
Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio
Biogen shares soar after patent victory
Privacy Center | Biogen
Biogen - GPTWⓇ MÉXICO
Biogen taps Envisagenics' AI to speed up RNA splicing R&D | pharmaphorum
Motor Neurone Disease: investigational drug granted accelerated ...
Healthcare Professionals
Biogen's New Alzheimer's Drug: What You Need to Know Now - Memory ...
Biogen's Big Alzheimer's Presentation on Wednesday: What You Need to ...
Biogen's Immunology Pipeline Has Long-Term Potential: Analyst
Biogen-UCB's lupus drug meets main goal of late-stage trial | Reuters
In this photo illustration, the American multinational biotechnology ...
Biogen’s Singhal Offers A Look Into Company's Pipeline Review
Biogen, rotated, white background, logo, brand name Stock Photo - Alamy
Biogen, UCB Reveal Details Behind Surprise Late-Stage Win in Lupus, Eye ...
Biogen: To Report First Quarter 2025 Financial Results on the 1st of ...
Bio gen
Biogen's Boston conference continues to be leading source of ...
Biogen, Eisai Win FDA Approval For Highly Anticipated Alzheimer's Drug ...
:max_bytes(150000):strip_icc()/GettyImages-1742678123-27c9d18e27274ea7a0a3ff747178c5bb.jpg)
